首页 > 市场调查报告书 > 医疗设备

体外诊断人工智能诊断用人工智能

市场调查报告书

商品编码

1789659

欧洲的AI支援医疗影像市场:2025年

Europe AI-assisted Medical Imaging Market

出版日期: 2025年08月13日 | 出版商:

Marketstrat, Inc. | 英文 88 Pages | 订单完成后即时交付

价格

简介目录图表

报告元资料

地理覆盖范围 欧洲（德国、法国、英国、义大利、西班牙及其他地区）
影像模式 CT、MRI、X光/DR、超音波、PET/核子医学
临床领域 肿瘤科、神经内科/中风科、心臟科、呼吸科/肺科、MSK/骨科、综合诊断
应用领域 早期检测/分诊、诊断准确性与分类、工作流程/效率、预后与治疗、影像增强/剂量、分割/特征提取、跨模态整合
收入来源 硬体（工厂资本支出提升）、软体（企业订阅的固定许可证）、服务（实施/验证/支援）、云端/按使用付费（按扫描付费）。
最终用途医院、诊断影像中心、诊所、远距放射科、其他供应商

报告摘要

欧洲人工智慧辅助医学影像市场：2025报告衡量并预测了德国、法国、英国、义大利、西班牙和其他欧洲国家在 CT、MRI、X 光/DR、超音波和 PET/核医领域的人工智慧支出。我们按医疗模式、临床领域、应用、收入来源、最终用户组织和人工智慧技术，提供 2023-2024 年的实际结果和 2025-2032 年的预测，以及欧洲特定的 GTM 成长与成熟度、生态系统协作以及解决方案采用与成长框架。这份 88 页的 Marketstrat™ Markintel™ Pulse 报告专注于欧洲医学影像领域的人工智慧发展。区域框架——GTM 成长与成熟度（供应商视角）、生态系统协作矩阵以及解决方案采用与成长——将证据转化为排序、合作和定价决策。针对德国、法国、英国、义大利、西班牙和其他欧洲国家的国家/地区章节，提供了 GTM 准备、定价契合度和分层客户格局的见解。我们的方法将欧洲自上而下的支出模型与自下而上的附加率 x ASP 引擎（按医疗模式和国家/地区划分）进行协调，并根据监管备案文件、经审计的财务数据、持牌专家演讲和 RWE 进行加权。国家现状：德国将在 2027 年前转向模组化 SaaS；英国将优先考虑云端/使用定价；法国将优先考虑整合和合规性；义大利将透过 PNRR 发展由 MR 驱动的 AI；西班牙有理由减少积压；RoE 集群展现出强大的改造潜力。决策框架：GTM 的成长和成熟、生态系统协作以及解决方案的采用和发展——所有这些都在欧洲层面进行。

本报告的受众

OEM 领导层（产品、区域总经理、策略）
AI 专业供应商与平台（创办人、销售主管、合作伙伴）
供应商网路（资讯长/首席医疗官、放射科主任、采购）
投资人与股票分析师（医疗技术/人机互动技术）
顾问公司（行销、定价、尽职调查）

您提供哪些决策支援（目前/下一季）？

您为企业/平台交易捆绑哪些解决方案？为市场上市捆绑哪些解决方案？
以国家定价（期限或企业版；订阅或基于使用量）
试点到规模化计画与采购节奏和证据预期保持一致
按国家/地区划分的合作伙伴路线（OEM 商店、PACS 市场、云端交换）

欧洲关键数据：截至 2032 年的总和成长里程碑
按模式、临床领域、应用、收入来源、最终用途和 AI 技术细分
国家章节（德国、法国、英国、义大利、西班牙和欧洲其他地区）
GTM 准备就绪雷达、国家/地区定价矩阵、按层级划分的客户格局和预测表
区域框架（欧洲层级）
- GTM 成长与成熟度 - 供应商地图
- 生态系协作矩阵 (ECM)
- 解决方案采用与成长矩阵
方法论：双视角模型（自上而下对齐，自下而上附着率 x 平均售价），证据加权，品质保证检查

为何购买此脉搏报告

统一模型：跨模态、国家/地区、应用和收入来源对齐数据
证据加权：将监管、财务和访谈讯号与清晰的置信度权重结合
行动导向：框架将数据驱动到定序、合作和定价
比客製化研究更快：现已提供以欧洲为中心的研究范围。

方法概述

双视角架构：自上而下的欧洲支出锚定总额，以及自下而上的每种模式和国家/地区 x ASP 引擎规模的药品说明书创建率
证据支柱：CE MDR/UKCA 备案、经审计的财务报表、持牌专家电话记录、同侪审查或会议 RWE
品质保证：表格/图表之间的数值一致性、记录的来源路径、复审员的编辑检查

关于本 "脉搏报告"
范围与细分
Marketstrat 的 "洞察到行动" 方法
双视角架构
自上而下的市场漏斗（欧洲）
自下而上的连线速率流（欧洲）
按国家和细分市场建模
证据可靠性 - 密度与可靠性（欧洲）
本脉动报告所包含的区域框架
GTM 国家/地区工具
品质保证与治理
限制与缓解措施

第三部分 - 欧洲市场分析

市场概览与分析
- 市场快照
- 结构性需求讯号
- 监理与融资格局（2024-2028）
- 市场区隔：2032（价值占有率）
- 竞争热图(2024-2026)
- 执行手册 (2024-2027)
- 行动导向建议
欧洲市场估值与预测 (2023-2032，百万美元)
Markintel 成长成熟度矩阵 - 欧洲
Markintel 生态系协作矩阵 (ECM) - 欧洲
Markintel 解采用与成长矩阵 - 欧洲
AI 应用率 - 欧洲
GTM 概览 - 欧洲

第四部分 - 德国市场

德国市场概览
宏观与流行病学
医疗体系与资金状况
监理与证据路径
竞争格局
策略要点与建议
德国市场（依临床）区域
德国市场依模式划分（2023-2032，百万美元）
德国市场依收入来源划分（2023-2032，百万美元）
德国市场依临床应用划分（2023-2032，百万美元）
德国市场依最终使用机构划分（2023-2032，百万美元）
德国市场依人工智慧技术划分（2023-2032，百万美元）
GTM 概览 - 德国

第五部 - 法国市场

市场概要：法国
法国市场预估与预测（2023-2032）
GTM 概览 - 法国

第六部分 - 英国市场

英国市场概览
英国市场
英国市场预估与预测(2023-2032)
GTM 概览 - 英国

第七部分 - 义大利市场

市场概览与总结：义大利
义大利市场预测 (2023-2032)
GTM 概览 - 义大利

第八部 - 西班牙市场

西班牙市场概况与总结
策略要点
西班牙市场评估与预测 (2023-2032)
GTM 概览 - 西班牙

第九章 - 欧洲其他地区市场

市场概览：欧洲其他地区
策略要点
欧洲医学影像 AI 市场 (2023-2032)
GTM 概览 - 欧洲其他地区欧洲

简介目录图表

Product Code: MINTP-M01121

Report Metadata

Geographic scope: Europe (Germany, France, United Kingdom, Italy, Spain, Rest of Europe)
Modalities: CT, MRI, X ray/DR, Ultrasound, PET/Nuclear
Clinical areas: Oncology, Neurology/Stroke, Cardiology, Respiratory/Lung, MSK/Ortho, General Diagnostic
Applications: Early detection/triage; diagnostic accuracy & classification; workflow/efficiency; prognosis & treatment; image enhancement/dose; segmentation/feature extraction; integration across modalities
Revenue streams: Hardware (factory attach CAPEX uplift), Software (fixed licenses incl. enterprise subscriptions), Service (implementation/validation/support), Cloud/Pay per Use (metered per scan)
End use: Hospitals, Imaging Centers, Clinics, Teleradiology, Other providers

Report Summary

The Europe - AI assisted Medical Imaging Pulse report sizes and forecasts AI spend across CT, MRI, X ray/DR, Ultrasound, and PET/Nuclear for DE, FR, UK, IT, ES, RoE. It provides 2023-24 actuals and a 2025-2032 forecasts by modality, clinical area, application, revenue stream, end use organization, and AI technology-plus GTM Growth & Maturity, Ecosystem Collaboration, and Solution Adoption & Growth frameworks tailored to Europe.

This 88 page Markintel(TM) Pulse report from Marketstrat(TM) delivers a Europe only view of AI in medical imaging. Regional frameworks-GTM Growth & Maturity (vendor view), Ecosystem Collaboration Matrix, and Solution Adoption & Growth-translate evidence into sequencing, partnering, and pricing decisions. Country chapters for Germany, France, the UK, Italy, Spain, and RoE include GTM readiness, pricing fit, and tiered customer landscapes. Methodology reconciles a top down Europe spend model with bottom up attach rate x ASP engines by modality and country, weighted by regulatory filings, audited financials, licensed expert transcripts, and RWE.

Country reality: Germany pivots to modular SaaS by 2027; UK favors cloud/usage pricing; France prioritizes integration & compliance; Italy grows MR led AI via PNRR; Spain's case is backlog reduction; RoE clusters show strong retrofit potential.

Decision ready frameworks: GTM Growth & Maturity, Ecosystem Collaboration, Solution Adoption & Growth-all Europe level.

Who should use this report:

OEM leadership (product, regional GMs, strategy)
Specialist AI vendors & platforms (founders, sales leaders, partnerships)
Provider networks (CIO/CMIO, radiology chairs, procurement)
Investors & equity analysts (MedTech/HCIT)
Consulting & advisory firms (GTM, pricing, diligence)

What decisions it supports (now/next quarter)

Which solutions to bundle for enterprise/platform deals vs list in marketplaces.
Pricing fit-term vs enterprise subscription vs usage based by country.
Pilot to scale plans tied to procurement cadence and evidence expectations.
Partner routes (OEM stores, PACS marketplaces, cloud exchanges) per country.

What's inside:

Europe key numbers: totals and growth milestones through 2032.
Breakdowns by modality, clinical area, application, revenue stream, end use, AI technology.
Country chapters (DE, FR, UK, IT, ES, RoE) with: GTM readiness radar, country pricing matrix, tiered customer landscape, and forecast tables.
Regional frameworks (Europe level):
- GTM Growth & Maturity - vendor map
- Ecosystem Collaboration Matrix (ECM)
- Solution Adoption & Growth Matrix
Methodology: dual lens model (top down reconciliation; bottom up attach rate x ASP), evidence weighting, QA checks.

Why buy this Pulse report:

One coherent model: numbers reconcile across modality, country, application, and revenue stream.
Evidence weighted: regulatory, financial and interview based signals are combined with clear confidence weights.
Action oriented: frameworks translate data into sequencing, partnering, and pricing moves.
Faster than a custom study: focused Europe scope you can use today.

Methods in brief:

Dual lens architecture: top down Europe spend anchors totals; bottom up attach rate x ASP engines size each modality and country.
Evidence pillars: CE MDR/UKCA filings, audited financials, licensed expert call transcripts, and peer reviewed or conference RWE.
QA: numeric parity across tables/figures; documented source trail; second reader editorial check.

SECTION 1 - EXECUTIVE SUMMARY

What this Pulse Covers
Key Numbers Snapshot (Europe)
What's Driving Europe's Curve
Where the Value Pools Form
Country Outlook-Six Different Routes to Scale
Near term Watchlist (Next 12-18 Months)
What to do now (Insights -> Action)
- OEMs
- Pure plays
- Providers & Networks
- Investors

SECTION 2 - RESEARCH METHODOLOGY

About this Pulse Report
Scope & Segmentation
Marketstrat's "Insights -> Action" Approach
Dual lens Architecture
Top down Market Funnel (Europe)
- How it Works in the Model
Bottom up Attach rate Flow (Europe)
What we model for Each Country and Segment
Evidence Confidence - Density vs Reliability (Europe)
- Reading the Bubbles
Regional Frameworks Included in this Pulse Report
GTM Country Tools
Quality Assurance & Governance
Limitations & Mitigations

SECTION 3 - EUROPEAN MARKET ANALYSIS

Market Overview & Analysis
- Market Snapshot
- Structural Demand Signals
- Regulatory & Funding Landscape (2024-2028)
- Market Segmentation 2032 (value share)
- Competitive Heat Map (2024-26)
- Execution Playbook (2024-2027)
- Action-Oriented Recommendations
European Market Estimates and Forecasts by Country (2023-2032, USD Mill)
- Five Forces Shaping Adoption
- Country Archetypes & What Sells
- Near term Adoption Runway (2024-27)
- Strategic Implications
- Regulatory Velocity by Company - Europe
Markintel Growth Maturity Matrix - Europe
- Landscape Snapshot
- Why the Quadrant Looks the Way it Does
- Key Competitive Dynamics
- Strategic Takeaways
- Bottom Line
- M&A Watchlist - Europe
- Competitive Dataset - Europe
- Growth & Maturity Highlights - Europe
Markintel Ecosystem Collaboration Matrix (ECM) - Europe
- Quadrant Commentary & European Illustrations
- Action Checklist
Markintel Solution Adoption & Growth Matrix - Europe
- Quadrant Deep Dive
- What Moves a Solution from One Box to the Next?
- Strategic Guidance
AI Attach Rate - Europe
- OEM AI Attach Rate
- Attach Rate Trends - Europe
- AI Revenue Split - Factory vs Retrofit Attach -- Europe
GTM at a Glance - Europe
- Channel & Pricing Matrix (2025-2028)
- GTM Readiness Radar - Europe
- Tiered Customer Landscape (2032 View)
- GTM Timeline (2025 -> 2028) - Europe
- Adjacency Opportunity Radar (2026+) - Europe
- Regulatory x Funding Heatmap - Europe
- AI Imaging Whitespace Matrix - Europe
- Fast Strategic Cues (2025 playbook)

SECTION 4 - GERMAN MARKET

Market Overview - Germany
Macro & Epidemiology
Health system & Funding Landscape
Regulatory & Evidence Pathway
Competitive Landscape
Strategic Takeaways & Recommendations
German Market by Clinical Area
- Forecast by Clinical Area (2023-2032, USD Mill)
- Primary Growth Catalysts
- Strategic Messages for Stakeholders
- Key Takeaways
German Market by Modality (2023-2032, USD Million)
- Forecast by Modality (2023-2032, USD Mill)
- Key Inflection by Modality
- What's Driving Each Modality
- Strategic Implications
German Market by Revenue Stream (2023-2032, USD Million)
- Forecast by Revenue Stream (2023-2032, USD Mill)
- Revenue Streams and Drivers
- Key Dynamics by Stream
- Strategic Guidance
German Market by Clinical Application (2023-2032, USD Million)
- Forecast by Clinical Application (2023-2032, USD Mill)
- What is Driving Each Bucket
- Strategic Messages
- Action Playbook
German Market by End-Use Organization (2023-2032, USD Million)
- Forecast by End-Use Organization (2023-2032, USD Mill)
- Segments Review
- Strategic Implications
German Market by AI Technology (2023-2032, USD Million)
- Forecast by AI Technology (2023-2032, USD Mill)
- Germany - AI Imaging Market by Core Technology
- Why Deep Learning Keeps the Lion's Share
- Break-out Growth Themes
- Strategic Playbook
GTM at-a-Glance - Germany
- Channel x Pricing Matrix
- GTM Readiness Radar - Germany
- Tiered Customer Landscape
- GTM Timeline - Germany
- Fast Strategic Cues

SECTION 5 - FRENCH MARKET

Market Summary: France
- Top line Snapshot - France
- Key Market Dynamics
- Strategic Takeaways
- Top 3 Recommendations
- French Market Speed scan - Market Analysis (2024-2032)
French Market Estimates and Forecasts (2023-2032)
- French Market by Clinical Area (2023-2032)
- French Market by Modality (2023-2032)
- French Market by Revenue Stream (2023-2032)
- French Market by Clinical Application (2023-2032)
- French Market by End-Use Organization (2023-2032)
- French Market by AI Technology (2023-2032)
GTM at a Glance - France
- Channel x Pricing Matrix
- GTM Readiness Radar - What Counts Most in France
- GTM Timeline (2024-30) - France
- Spend Potential by Customer Tier - France

SECTION 6 - UNITED KINGDOM MARKET

Market Overview - United Kingdom
UK Market Speed Scan
- Scale & growth
- Policy & funding
- Demand triggers
- Procurement routes
- Competitive Field
- Winning playbook 2024-27
UK Market Estimates and Forecasts (2023-2032)
- UK Market by Clinical Area (2023-2032)
- UK Market by Modality (2023-2032)
- UK Market by Revenue Stream (2023-2032)
- UK Market by Clinical Application (2023-2032)
- UK Market by End-Use Organization (2023-2032)
- UK Market by AI Technology (2023-2032)
GTM at a Glance - UK
- Channel x Pricing Matrix
- GTM Readiness Radar - UK
- Fast Strategic Cues
- Tiered Customer Landscape - UK
- GTM Timeline (2024-29) - UK

SECTION 7 - ITALIAN MARKET

Market Overview & Summary: Italy
- What Makes Italy Unique in the EU Context
- Strategic Takeaways
Italian Market Estimates & Forecasts (2023-2032)
- Italian Market by Clinical Area (2023-2032)
- Italian by Modality (2023-2032)
- Italian Market by Revenue Stream (2023-2032)
- Italian Market by Clinical Application (2023-2032)
- Italian Market by End-Use Organization (2023-2032)
- Italian Market by AI Technology (2023-2032)
GTM at a Glance - Italy
- Channel x Pricing Matrix
- Tiered Customer Landscape & Spend Potential (2032) - Italy
- GTM Readiness Radar - Italy
- GTM Timeline (2024-29) - Italy
- Fast Strategic Cues

SECTION 8 - SPANISH MARKET

Market Overview & Summary - Spain
Strategic Takeaways
Spanish Market Estimates and Forecasts (2023-2032)
- Spanish Market by Clinical Area (2023-2032)
- Spanish Market by Modality (2023-2032)
- Spanish Market by Clinical Application (2023-2032)
- Spanish Market by Revenue Stream (2023-2032)
- Spanish Market by End-Use Organization (2023-2032)
- Spanish Market by AI Technology (2023-2032)
GTM at a Glance - Spain
- GTM Readiness Radar - Spain
- Channel x Pricing Matrix
- Tiered Customer Landscape - Spain
- GTM Timeline - Spain

SECTION 9 -REST OF EUROPE (ROE) MARKET

Market Overview: Rest of Europe (ROE)
- Size & trajectory
- Why Growth Accelerates
- Risks / Headwinds
Strategic Takeaways
Rest of European Market for AI in Medical Imaging (2023-2032)
- Rest of European Market by Clinical Area (2023-2032)
- Rest of European Market by Modality (2023-2032)
- Rest of European Market by Revenue Stream (2023-2032)
- Rest of European Market by Clinical Application (2023-2032)
- Rest of European Market by End-Use Organization (2023-2032)
- Rest of European Market by AI Technology (2023-2032)
GTM at a Glance - Rest of Europe (ROE)
- GTM Readiness Radar - ROE
- Tiered Customer Landscape - ROE
- GTM Timeline - ROE
- Channel x Pricing Matrix
- Adjacency-Opportunity Matrix (2026-2030)
- Country-Cluster Framework & Strategic Playbook
- White-Space Partnership Matrix
- Regulatory Funding Heatmap (ROE Clusters)
- Fast Strategic Cues

简介目录图表

List of Tables

Table 1: AI Imaging Market by Country - Europe (2023-2032, USD Mill)
Table 2: German Market for AI in Medical Imaging by Clinical Area (2023-2032, USD Million)
Table 3: German Market for AI in Medical Imaging by Modality (2023-2032, USD Million)
Table 4: German Market for AI in Medical Imaging by Revenue Stream (2023-2032, USD Million)
Table 5: German Market for AI in Medical Imaging by Clinical Application (2023-2032, USD Million)
Table 6: German Market for AI in Medical Imaging by End-Use Organization (2023-2032, USD Million)
Table 7: German Market for AI in Medical Imaging by AI Technology (2023-2032, USD Million)
Table 8: French Market for AI in Medical Imaging by Clinical Area (2023-2032, USD Million)
Table 9: French Market for AI in Medical Imaging by Modality (2023-2032, USD Million)
Table 10: French Market for AI in Medical Imaging by Revenue Stream (2023-2032, USD Million)
Table 11: French Market for AI in Medical Imaging by Clinical Application (2023-2032, USD Million)
Table 12: French Market for AI in Medical Imaging by End-Use Organization (2023-2032, USD Million)
Table 13: French Market for AI in Medical Imaging by AI Technology (2023-2032, USD Million)
Table 14: UK Market for AI in Medical Imaging by Clinical Area (2023-2032, USD Million)
Table 15: UK Market for AI in Medical Imaging by Modality (2023-2032, USD Million)
Table 16: UK Market for AI in Medical Imaging by Revenue Stream (2023-2032, USD Million)
Table 17: UK Market for AI in Medical Imaging by Clinical Application (2023-2032, USD Million)
Table 18: UK Market for AI in Medical Imaging by End-Use Organization (2023-2032, USD Million)
Table 19: UK Market for AI in Medical Imaging by AI Technology (2023-2032, USD Million)
Table 20: Italian Market for AI in Medical Imaging by Clinical Area (2023-2032, USD Million)
Table 21: Italian Market for AI in Medical Imaging by Modality (2023-2032, USD Million)
Table 22: Italian Market for AI in Medical Imaging by Revenue Stream (2023-2032, USD Million)
Table 23: Italian Market for AI in Medical Imaging by Clinical Application (2023-2032, USD Million)
Table 24: Italian Market for AI in Medical Imaging by End-Use Organization (2023-2032, USD Million)
Table 25: Italian Market for AI in Medical Imaging by AI Technology (2023-2032, USD Million)
Table 26: GTM Readiness Radar - Italy
Table 27: Spanish Market for AI in Medical Imaging by Clinical Area (2023-2032, USD Million)
Table 28: Spanish Market for AI in Medical Imaging by Modality (2023-2032, USD Million)
Table 29: Spanish Market for AI in Medical Imaging by Clinical Application (2023-2032, USD Million)
Table 30: Spanish Market for AI in Medical Imaging by Revenue Stream (2023-2032, USD Million)
Table 31: Spanish Market for AI in Medical Imaging by End-Use Organization (2023-2032, USD Million)
Table 32: Spanish Market for AI in Medical Imaging by AI Technology (2023-2032, USD Million)
Table 33: Rest of Europe Market for AI in Medical Imaging by Clinical Area (2023-2032, USD Million)
Table 34: Rest of Europe Market for AI in Medical Imaging by Modality (2023-2032, USD Million)
Table 35: Rest of Europe Market for AI in Medical Imaging by Revenue Stream (2023-2032, USD Million)
Table 36: Rest of Europe Market for AI in Medical Imaging by Clinical Application (2023-2032, USD Million)
Table 37: Rest of Europe Market for AI in Medical Imaging by End-Use Organization (2023-2032, USD Million)
Table 38: Rest of Europe Market for AI in Medical Imaging by AI Technology (2023-2032, USD Million)
Table 39: Adjacency-Opportunity Matrix - ROE (2026-2030)
Table 40: White-Space Partnership Matrix - ROE